Ovarian cancer clinical trials: Study the studies to terminate the terminations.
Publication
, Conference
Spinosa, D; Howell, E; Williams, D; Watson, C; Akinyemiju, TF; Previs, RA
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Spinosa, D., Howell, E., Williams, D., Watson, C., Akinyemiju, T. F., & Previs, R. A. (2020). Ovarian cancer clinical trials: Study the studies to terminate the terminations. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Spinosa, Daniel, Elizabeth Howell, D’Erryl Williams, Catherine Watson, Tomi F. Akinyemiju, and Rebecca A. Previs. “Ovarian cancer clinical trials: Study the studies to terminate the terminations.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Spinosa D, Howell E, Williams D, Watson C, Akinyemiju TF, Previs RA. Ovarian cancer clinical trials: Study the studies to terminate the terminations. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Spinosa, Daniel, et al. “Ovarian cancer clinical trials: Study the studies to terminate the terminations.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Spinosa D, Howell E, Williams D, Watson C, Akinyemiju TF, Previs RA. Ovarian cancer clinical trials: Study the studies to terminate the terminations. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences